Schedule 13G ownership disclosure

REVANCE THERAPEUTICS INC

Common Stock, par value $0.001 per share · CUSIP: 761330109

Event date: 2025-01-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Glazer Capital, LLC

    Shares: 7,210,121.00 · Class: 6.87%

  • Paul J. Glazer

    Shares: 7,210,121.00 · Class: 6.87%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001076809-25-000009
Form type
SCHEDULE 13G
Filer
GLAZER CAPITAL, LLC
CIK
CIK 1076809
Filed
Feb 06, 2025
Reporting period
Jan 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub